An angiotensin-converting enzyme-2-derived heptapeptide GK-7 for SARS-CoV-2 spike blockade

The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a global concern and necessitates efficient drug antagonists. Angiotensin-converting enzyme-2 (ACE2) is the main receptor of SARS-CoV-2 spike 1 (S1), which med...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Songling, Zhao, Gaomei, Wei, Zhuanzhuan, Chen, Yin, Zhao, Jianqi, He, Yongwu, He, Ying-Juan, Gao, Jining, Chen, Shilei, Du, Changhong, Wang, Tao, Sun, Wei, Huang, Yi, Wang, Cheng, Wang, Junping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375220/
https://www.ncbi.nlm.nih.gov/pubmed/34419496
http://dx.doi.org/10.1016/j.peptides.2021.170638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375220/
https://www.ncbi.nlm.nih.gov/pubmed/34419496
http://dx.doi.org/10.1016/j.peptides.2021.170638

Ejemplares similares